Current Diabetes Reports

, 17:104 | Cite as

Minimally Disruptive Medicine for Patients with Diabetes

  • Valentina Serrano
  • Gabriela Spencer-Bonilla
  • Kasey R. Boehmer
  • Victor M. Montori
Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Health Care Delivery Systems and Implementation in Diabetes


Purpose of review

Patients with diabetes must deal with the burden of symptoms and complications (burden of illness). Simultaneously, diabetes care demands practical and emotional work from patients and their families, work to access and use healthcare and to enact self-care (burden of treatment). Patient work must compete with the demands of family, job, and community life. Overwhelmed patients may not have the capacity to access care or enact self-care and will thus experience suboptimal diabetes outcomes.

Recent findings

Minimally disruptive medicine (MDM) is a patient-centered approach to healthcare that prioritizes patients’ goals for life and health while minimizing the healthcare disruption on patients’ lives.


In patients with diabetes, particularly in those with complex lives and multimorbidity, MDM coordinates healthcare and community responses to improve outcomes, reduce treatment burden, and enable patients to pursue their life’s hopes and dreams.


Minimally disruptive medicine Patient-centered care Burden of treatment Patient capacity Diabetes 



We would like to thank Ian Hargraves for his collaboration with the figure of this manuscript. The authors are part of the International Minimally Disruptive Medicine Research Group (

Author Contributions

VS and VMM served as overall principal investigators, conducted the literature review, and wrote and reviewed the manuscript. GSB and KB helped with the literature reviewed, revised the manuscript, and assisted with adaptations. All authors read and approved the final manuscript. VMM is the guarantor of this work.

Funding Information

GSB was supported by CTSA Grant Number TL1TR000137 from the National Center for Advancing Translational Science (NCATS) and Grant Number 3R01HL131535-01S1 from the National Heart Lung and Blood Institute (NHLBI). VMM and KRB were partially supported by Grant Number UL1TR000135 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the author and do not necessarily represent the official view of the NIH. The content of this work is solely the responsibility of the authors and does not necessarily represent the official opinion of NIH.

Compliance with Ethical Standards

Conflict of Interest

Valentina Serrano, Gabriela Spencer-Bonilla, Kasey R. Boehmer, and Victor M. Montori declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    WHO: Global Report on Diabetes. World Health Organization. 2016.Google Scholar
  2. 2.
    Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010;87:15–9.CrossRefPubMedGoogle Scholar
  3. 3.
    van Dieren S, Beulens J, van der Schouw Y, Grobbee D, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17:S3–8.PubMedGoogle Scholar
  4. 4.
    Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010;8:18.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Russell LB, Suh D-C, Safford M. Time requirements for diabetes self-management: too much for many. J Fam Pract. 2005;54:52–6.PubMedGoogle Scholar
  6. 6.
    • Tran V-T, Barnes C, Montori VM, Falissard B, Ravaud P. Taxonomy of the burden of treatment: a multi-country web-based qualitative study of patients with chronic conditions. BMC Med. 2015;13:115. This article describes the taxonomy of burden of treatment, based on surveys applied to more than 1000 patients with chronic conditions CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Lipska KJ, Ross JS, Van Houten HK, Beran D, Yudkin JS, Shah ND. Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010. JAMA. 2014;311:2331–3.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    •• May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, et al. Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14:281. This manuscript helps us understand the work of being a patient with multi-morbidity and the resources necessary to respond to the demands of illness and treatments CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Klimek P, Kautzky-Willer A, Chmiel A, Schiller-Frühwirth I, Thurner S. Quantification of diabetes comorbidity risks across life using nation-wide big claims data. PLoS Comput Biol. 2015;11:e1004125.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Lin P-J, Kent DM, Winn A, Cohen JT, Neumann PJ. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care. 2015;21:e23–34.PubMedGoogle Scholar
  11. 11.
    Jacobsen PB, Donovan KA, Trask PC, Fleishman SB, Zabora J, Baker F, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005;103:1494–502.CrossRefPubMedGoogle Scholar
  12. 12.
    Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6:246–52.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    McCoy RG, Lipska KJ, Yao X, Ross JS, Montori VM, Shah ND. Intensive treatment and severe hypoglycemia among adults with type 2 diabetes. JAMA Intern Med. 2016;176:969–78.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lipska KJ, Montori VM. Glucose control in older adults with diabetes mellitus—more harm than good? JAMA Intern Med. 2013;173:1306–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Spencer-Bonilla G, Rodriguez-Gutierrez R, Montori VM. Minimally disruptive diabetes care for the elderly. Diabetes Technol Ther. 2016;18:759–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Duke KS, Raube K, Lipton HL. Patient-assistance programs: assessment of and use by safety-net clinics. Am J Health Syst Pharm. 2005;62Google Scholar
  17. 17.
    Wharam JF, Zhang F, Eggleston EM, Lu CY, Soumerai S, Ross-Degnan D: Diabetes outpatient care and acute complications before and after high-deductible insurance enrollment: a Natural Experiment for Translation in Diabetes (NEXT-D) study. JAMA Internal Medicine 2017.Google Scholar
  18. 18.
    •• Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65:1041–51. This article introduces the Cumulative Complexity Model, a functional and patient-centered model of patient complexity that contributes to formulate Minimally Disruptive Medicine interventions CrossRefPubMedGoogle Scholar
  19. 19.
    Boehmer KR, Gionfriddo MR, Rodriguez-Gutierrez R, Dabrh AMA, Leppin AL, Hargraves I, et al. Patient capacity and constraints in the experience of chronic disease: a qualitative systematic review and thematic synthesis. BMC Fam Pract. 2016;17:127.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wyatt KD, Stuart LM, Brito JP, Leon BC, Domecq JP, Prutsky GJ, et al. Out of context: clinical practice guidelines and patients with multiple chronic conditions: a systematic review. Med Care. 2014;52:S92–S100.CrossRefPubMedGoogle Scholar
  21. 21.
    •• May C, Montori VM, Mair FS: We need minimally disruptive medicine. BMJ: British Medical Journal (Online) 2009, 339. This was the first publication in which the term “Minimally disruptive Medicine” was coined, highlighting why the way we take care of patients can cause disruption and suffering and why we must seek an alternative. Google Scholar
  22. 22.
    • Eton DT, Yost KJ, Lai J-S, Ridgeway JL, Egginton JS, Rosedahl JK, Linzer M, Boehm DH, Thakur A, Poplau S: Development and validation of the Patient Experience with Treatment and Self-Management (PETS): a patient-reported measure of treatment burden. Quality of Life Research 2016:1–15. This paper presents the development and validation of a new instrument to measure burden of treatment in patients with multitimorbidity. Google Scholar
  23. 23.
    Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–75.CrossRefPubMedGoogle Scholar
  24. 24.
    Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clin Diabetes. 2004;22:123–7.CrossRefGoogle Scholar
  25. 25.
    Anderson RM, Funnell MM. Patient empowerment: reflections on the challenge of fostering the adoption of a new paradigm. Patient Educ Couns. 2005;57:153–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Heath I. William Pickles Lecture 1999: ‘Uncertain clarity’: contradiction, meaning, and hope. Br J Gen Pract. 1999;49:651–7.PubMedCentralGoogle Scholar
  27. 27.
    Eton DT, Elraiyah TA, Yost KJ, Ridgeway JL, Johnson A, Egginton JS, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Tran V-T, Harrington M, Montori VM, Barnes C, Wicks P, Ravaud P. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform. BMC Med. 2014;12:109.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Spencer-Bonilla G, Quiñones AR; Montori VM: Assessing the burden of treatment. Submitted for publication.Google Scholar
  30. 30.
    Boehmer K, Shippee N, Beebe T, Montori V. Pursuing minimally disruptive medicine: correlation of patient capacity with disruption from illness and healthcare-related demands. J Clin Epidemiol. 2016;74:227–36.CrossRefPubMedGoogle Scholar
  31. 31.
    Leppin AL, Montori VM, Gionfriddo MR: Minimally disruptive medicine: a pragmatically comprehensive model for delivering care to patients with multiple chronic conditions. In: Healthcare: 2015: Multidisciplinary Digital Publishing Institute; 2015: 50–63.Google Scholar
  32. 32.
    Arnheiter ED, Maleyeff J. Research and concepts: the integration of lean management and Six Sigma. TQM J. 2005;17:5.CrossRefGoogle Scholar
  33. 33.
    Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, Weir D, et al. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients’ treatment priorities and self-management? J Gen Intern Med. 2007;22:1635–40.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Andreassen LM, Kjome RLS, Sølvik UØ, Houghton J, Desborough JA. The potential for deprescribing in care home residents with type 2 diabetes. Int J Clin Pharm. 2016;38:977–84.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, et al. Quality of life and treatment satisfaction in adults with type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med. 2008;25:213–20.CrossRefPubMedGoogle Scholar
  36. 36.
    Hoogma R, Hammond P, Gomis R, Kerr D, Bruttomesso D, Bouter K, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2006;23:141–7.CrossRefPubMedGoogle Scholar
  37. 37.
    • Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015;58:429–42. This is the ADA and EASD Position Statement about management of type 2 diabetes patients, which mentions for the first time the importance of a patient-centered approach CrossRefPubMedGoogle Scholar
  38. 38.
    Magnan EM, Palta M, Johnson HM, Bartels CM, Schumacher JR, Smith MA. The impact of a patient’s concordant and discordant chronic conditions on diabetes care quality measures. J Diabetes Complicat. 2015;29:288–94.CrossRefPubMedGoogle Scholar
  39. 39.
    Makam AN, Nguyen OK. An evidence-based medicine approach to antihyperglycemic therapy in diabetes mellitus to overcome overtreatment. Circulation. 2017;135:180–95.CrossRefPubMedGoogle Scholar
  40. 40.
    Serrano V, Rodriguez-Gutierrez R, Hargraves I, Gionfriddo M, Tamhane S, Montori V. Shared decision-making in the care of individuals with diabetes. Diabet Med. 2016;33:742–51.CrossRefPubMedGoogle Scholar
  41. 41.
    Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167:1076–82.CrossRefPubMedGoogle Scholar
  42. 42.
    Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169:1560–8.CrossRefPubMedGoogle Scholar
  43. 43.
    KER Unit. Mayo Clinic. The Instrument for Patient Capacity Assessment (ICAN) [ Accessed 29 March 2017].
  44. 44.
    KER Unit. Mayo Clinic. My Life, My Healthcare—ICAN and Statin Choice used in single visit [ Accessed 29 March 2017.]
  45. 45.
    Norris SL, Chowdhury FM, Van Le K, Horsley T, Brownstein JN, Zhang X, et al. Effectiveness of community health workers in the care of persons with diabetes. Diabet Med. 2006;23:544–56.CrossRefPubMedGoogle Scholar
  46. 46.
    Tang TS, Funnell M, Sinco B, Piatt G, Palmisano G, Spencer MS, et al. Comparative effectiveness of peer leaders and community health workers in diabetes self-management support: results of a randomized controlled trial. Diabetes Care. 2014;37:1525–34.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Patient Education Research Center. Stanford University. Chronic disease self-management program [ Accessed 29 March 2017].
  48. 48.
    WellConnect Program. SE MN Partnership [ Accessed 29 March 2017.]
  49. 49.
    McAllister SJ, Vincent A, Hassett AL, Whipple MO, Oh TH, Benzo RP, et al. Psychological resilience, affective mechanisms and symptom burden in a tertiary-care sample of patients with fibromyalgia. Stress Health. 2015;31:299–305.CrossRefPubMedGoogle Scholar
  50. 50.
    Joyce P, Smith RE, Vitaliano PP, Jean CY, Mai S, Hillman M, et al. A person-focused analysis of resilience resources and coping in diabetes patients. Stress Health. 2010;26:51.CrossRefGoogle Scholar
  51. 51.
    Boehmer KR, Barakat S, Ahn S, Prokop LJ, Erwin PJ, Murad MH. Health coaching interventions for persons with chronic conditions: a systematic review and meta-analysis protocol. Syst Rev. 2016;5:146.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Boehmer K. What is capacity coaching? Minimally Disruptive Medicine Blog. 2016 [ Accessed 29 March 2017.]
  53. 53.
    Shepherd CW, While AE. Cardiac rehabilitation and quality of life: a systematic review. Int J Nurs Stud. 2012;49:755–71.CrossRefPubMedGoogle Scholar
  54. 54.
    Kelley AS, Meier DE. Palliative care—a shifting paradigm. N Engl J Med. 2010;363:781–2.CrossRefPubMedGoogle Scholar
  55. 55.
    Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complicat. 2006;20:26–33.CrossRefPubMedGoogle Scholar
  56. 56.
    Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996:511–44.Google Scholar
  57. 57.
    Boehmer KRD, Gionfriddo, MR Erwin P, Montori, VM: Minimally disruptive medicine model of care versus the chronic care model: a systematic review and thematic synthesis. Submitted to publication.Google Scholar
  58. 58.
    Tran V-T, Montori VM, Eton DT, Baruch D, Falissard B, Ravaud P. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med. 2012;10:68.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health affairs (Project Hope). 2008;27:759–69.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Valentina Serrano
    • 1
    • 2
  • Gabriela Spencer-Bonilla
    • 1
    • 3
    • 4
  • Kasey R. Boehmer
    • 1
  • Victor M. Montori
    • 1
  1. 1.Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of MedicineMayo ClinicRochesterUSA
  2. 2.Department of Nutrition, Diabetes and MetabolismEscuela de Medicina Pontificia Universidad Católica de ChileSantiagoChile
  3. 3.Mayo Graduate SchoolMayo ClinicRochesterUSA
  4. 4.School of MedicineUniversity of Puerto Rico Medical Sciences CampusSan JuanUSA

Personalised recommendations